Rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (ACPA), both well-recognized autoantibodies in RA, serve as key serological markers used in the diagnosis of RA and as indicators of poor prognosis [1,2]. Here, PRTN3 is linked to rheumatoid arthritis.